Delivery Order SPE2DB20D1109-SPE2DB25FP70U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,228.91 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,892.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This non-competitive delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,293.62 and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract includes no set-aside designation and is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,807.90 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical supply vehicle running...
- The Defense Logistics Agency awarded a delivery order valued at $7,416.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with a ceiling value of $6,711.35. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance to be completed by September 9, 2025, and fulfillment occurring at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,488.45 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for the diabetes medication, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency has awarded a delivery order valued at $1,691.15 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens. The order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.38 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price, non-set-aside delivery order represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,862.58 on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 12, 2025, and performance executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP70UDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,583.57 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Trulicity, a diabetes medication, exemplifies the company's role in supplying essential brand-name pharmaceuticals to support military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/8/25 |